Gianluca Rossetti
Direttore/Membro del Consiglio presso Engitix Ltd.
Provenienza dei contatti di primo grado di Gianluca Rossetti
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Engitix Ltd.
Engitix Ltd. Miscellaneous Commercial ServicesCommercial Services Engitix Ltd. is a preclinical stage biopharma British company that is developing breakthrough therapies for fibrosis and solid tumors using its patient-centric human extracellular matrix drug discovery platform. The company has drug discovery partnerships with Dompe Farmaceutici and Takeda for advanced fibrotic liver diseases and fibrostenotic inflammatory bowel disease. Engitix was established in 2016 to commercialize research from the Institute for Liver and Digestive Health at University College London. The company is headquartered in WestWorks, London, UK. Giuseppe Mazza and Massimo Pinzani founded the company, and Giuseppe Mazza has been the CEO since 2016.
7
| Holding Company | Miscellaneous Commercial Services | 7 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Gianluca Rossetti tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
MERCK KGAA | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
INNATE PHARMA | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Georgiamune, Inc.
Georgiamune, Inc. BiotechnologyHealth Technology Georgiamune, Inc. is a clinical stage biotechnology company that focuses on reprogramming immune signaling pathways to redirect the immune system to fight diseases. The company is based in Silver Spring, MD. The company has designed unique approaches to re-establish immune balance, and its scientific discoveries have led to pioneering immunotherapies targeting high unmet needs. Georgiamune's lead program, Gim-122, is a first-in-class, dual-functioning monoclonal antibody designed to overcome immune therapy resistance in cancer patients. In addition to its lead program, the company is advancing a pipeline of first-in-class therapies for cancer and autoimmune diseases. The company was founded by Samir N. Khleif, a world-renowned medical oncologist and researcher in the field of immunology and cancer, based on discoveries in his lab on novel mechanisms to modulate immune response. Samir N. Khleif has been the CEO since incorporation. | Biotechnology | Chief Tech/Sci/R&D Officer | |
The University of Southampton | College/University | Corporate Officer/Principal | |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal | |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
General Medical Council
General Medical Council Miscellaneous Commercial ServicesCommercial Services The General Medical Council provides business support services. The non-profit company is based in London, UK. The CEO of the British company is Charlie Massey. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Ichnos Sciences, Inc.
Ichnos Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ichnos Sciences, Inc. operates as a biotechnology company. It provides curative therapies that extend human life. The company was founded in 2019 and is headquartered in Paramus, NJ. | Miscellaneous Commercial Services | Director/Board Member | |
Imperial College London | College/University | Doctorate Degree | |
University of Palermo | College/University | Doctorate Degree | |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
CIRCIO HOLDING ASA | Biotechnology | Director/Board Member | |
MerLion Pharmaceuticals Pte Ltd.
MerLion Pharmaceuticals Pte Ltd. Miscellaneous Commercial ServicesCommercial Services MerLion Pharmaceuticals Pte Ltd. provides drug discovery and development services. It focuses on developing its lead antibacterial candidate, finafloxacin, through early and mid-stage clinical trials. The company was founded in 2002 and is headquartered in Singapore. | Miscellaneous Commercial Services | Chief Executive Officer | |
First Light Fusion Ltd.
First Light Fusion Ltd. Miscellaneous Commercial ServicesCommercial Services First Light Fusion Ltd. manages a research intensive company in energy and process engineering. It engages in developing technology for inertial confinement fusion, using a radically different approach. The firm discovers implosion processes for electricity generation. The company was founded by Yiannis Ventikos and Nicholas Hawker in 2011 and is headquartered in Begbroke, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
London School of Economics & Political Science | College/University | Undergraduate Degree | |
BlueCrest Capital Management Ltd. (Jersey)
BlueCrest Capital Management Ltd. (Jersey) Investment ManagersFinance BlueCrest Capital Management Ltd. (BlueCrest) is a single-family office headquartered in St. Helier, UK. They are a subsidiary of WHR Investments Ltd., ultimately owned by BC Cayman Charitable Trust in Cayman Islands. The firm was previously a hedge fund management firm and in 2015, Michael Platt decided to turn BlueCrest into a firm that only managed his own money and money that belongs to BlueCrest partners and employees. | Investment Managers | Chief Executive Officer | |
BC Capital Management Services Ltd.
BC Capital Management Services Ltd. Investment ManagersFinance BC Capital Management Services Ltd. operates as an alternative investment manager. The company was founded in 2000 and is headquartered in London, the United Kingdom. | Investment Managers | Founder | |
BlueCrest Capital Management (UK) LLP
BlueCrest Capital Management (UK) LLP Investment ManagersFinance BlueCrest Capital Management (UK) LLP (BCM-UK) is an independent, Great Britain-based alternative asset management firm headquartered in London. The firm was founded in 2009 by Michael Platt and Bill Reeves to manage their flagship fund, BlueCrest Capital International. In 2015, they transitioned to a Private Investment Partnership and returned client capital. BCM-UK currently manages assets solely on behalf of their partners and employees. | Investment Managers | President | |
Dyson, Inc.
Dyson, Inc. Electronics/AppliancesConsumer Durables Dyson, Inc. operates as a technology company. It designs and manufactures household appliances such as vacuum cleaners, hand dryers, bladeless fans, heaters and hair dryers. The company was founded by James Dyson and is headquartered in Chicago, IL. | Electronics/Appliances | Director of Finance/CFO |
Statistiche
Distribuzione geografica
Regno Unito | 11 |
Stati Uniti | 7 |
Germania | 3 |
Francia | 2 |
Italia | 2 |
Settori
Commercial Services | 8 |
Health Technology | 6 |
Consumer Services | 5 |
Finance | 4 |
Health Services | 2 |
Posizioni
Director/Board Member | 14 |
Director of Finance/CFO | 5 |
Chief Executive Officer | 5 |
Corporate Officer/Principal | 5 |
Chief Tech/Sci/R&D Officer | 5 |
Contatti più connessi
Insiders | |
---|---|
Sonia Quaratino | 13 |
Stephen Brindle | 8 |
David Dally | 7 |
Mike E. Platt | 5 |
Giuseppe Mazza | 2 |
Eduardo Bravo | 2 |
Massimo Pinzani | 1 |
- Borsa valori
- Insiders
- Gianluca Rossetti
- Connessioni Società